IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2009 by National Cancer Institute (NCI).
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
San Diego Pacific Oncology & Hematology Associates
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00489944
First received: June 20, 2007
Last updated: January 9, 2014
Last verified: July 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |